Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Pediatrix Medical (MD) Non Operating Investment Income: 2022-2025

Historic Non Operating Investment Income for Pediatrix Medical (MD) over the last 4 years, with Q3 2025 value amounting to $309000.0.

  • Pediatrix Medical's Non Operating Investment Income fell 8229.23% to $309000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.9 million, marking a year-over-year decrease of 1174.6%. This contributed to the annual value of $1.1 million for FY2024, which is 2485.21% down from last year.
  • Latest data reveals that Pediatrix Medical reported Non Operating Investment Income of $309000.0 as of Q3 2025, which was down 8229.23% from $429000.0 recorded in Q2 2025.
  • In the past 5 years, Pediatrix Medical's Non Operating Investment Income registered a high of $1.7 million during Q3 2024, and its lowest value of -$2.7 million during Q1 2022.
  • Over the past 4 years, Pediatrix Medical's median Non Operating Investment Income value was $254500.0 (recorded in 2024), while the average stood at $126083.3.
  • The largest annual percentage gain for Pediatrix Medical's Non Operating Investment Income in the last 5 years was 17440000.0% (2024), contrasted with its biggest fall of 16615.5% (2024).
  • Over the past 4 years, Pediatrix Medical's Non Operating Investment Income (Quarter) stood at -$2.7 million in 2022, then skyrocketed by 148.84% to $1.3 million in 2023, then tumbled by 166.16% to -$862000.0 in 2024, then surged by 135.85% to $309000.0 in 2025.
  • Its Non Operating Investment Income was $309000.0 in Q3 2025, compared to $429000.0 in Q2 2025 and $779000.0 in Q1 2025.